Gene:
MOCS2
molybdenum cofactor synthesis 2

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this . To report a drug label with PGx, click here.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

This is a non-comprehensive list of genetic tests with pharmacogenetics relevance, typically submitted by the manufacturer and manually curated by PharmGKB. The information listed is provided for educational purposes only and does not constitute an endorsement of any listed test or manufacturer.

A more complete listing of genetic tests is found at the Genetic Testing Registry (GTR).

PGx Test Variants Assayed Related Drugs?

Overview

Alternate Names:  None
Alternate Symbols:  MOCO1
PharmGKB Accession Id: PA30903

Details

Cytogenetic Location: chr5 : q11.2 - q11.2
GP mRNA Boundary: chr5 : 52393892 - 52405598
GP Gene Boundary: chr5 : 52390892 - 52415598
Strand: minus
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

LinkOuts

Entrez Gene:
4338
OMIM:
252150
603708
UCSC Genome Browser:
NM_004531
RefSeq RNA:
NM_004531
NM_176806
RefSeq Protein:
NP_004522
NP_789776
RefSeq DNA:
AC_000048
AC_000137
NC_000005
NG_008435
NT_006713
NW_001838934
NW_922607
UniProtKB:
MOC2B_HUMAN (O96007)
MOC2A_HUMAN (O96033)
Ensembl:
ENSG00000164172
GenAtlas:
MOCS2
GeneCard:
MOCS2
MutDB:
MOCS2
ALFRED:
LO092935C
HuGE:
MOCS2
Comparative Toxicogenomics Database:
4338
ModBase:
O96007
O96033
HumanCyc Gene:
HS09033
HGNC:
7193

Common Searches